These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 29132330)

  • 1. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
    Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
    BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene-to-gene interactions and the association of TP53, XRCC1, TNFα, HMMR, MDM2 and PALB2 with breast cancer in Kyrgyz females.
    Isakova JT; Vinnikov D; Kipen VN; Talaibekova ET; Aldashev AA; Aldasheva NM; Makieva KB; Semetei Kyzy A; Bukuev NM; Tilekov EA; Shaimbetov BO; Kudaibergenova IO
    Breast Cancer; 2020 Sep; 27(5):938-946. PubMed ID: 32297247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.
    Datkhile KD; Gudur RA; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3065-3075. PubMed ID: 37774058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of the Arg399Gln polymorphisms of the XRCC1 gene with breast cancer risk in Kyrgiz women].
    Isakova ZhT; Makieva KB; E T Talaibekova ; Asambaeva DA; Sultangazieva BB; Aldashev AA
    Vopr Onkol; 2015; 61(6):941-4. PubMed ID: 26995983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of XRCC1 genetic variants on its tissue expression and breast cancer risk: A case-control study.
    Abdel Ghafar MT; El-Rashidy MA; Gharib F; Al-Ashmawy GM
    Environ Mol Mutagen; 2021 Aug; 62(7):399-408. PubMed ID: 34331480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of TP53 (R72P) and MDM2 (T309G) polymorphisms in breast cancer patients.
    Yadav P; Masroor M; Tanwer K; Mir R; Javid J; Ahmad I; Zuberi M; Kaza RC; Jain SK; Khurana N; Ray PC; Saxena A
    Clin Transl Oncol; 2016 Jul; 18(7):728-34. PubMed ID: 26553387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of polymorphic markers Arg72Pro of TP53 and T309g of MDM2 genes with non small cell lung cancer in Russians of Moscow region].
    Loginov VI; Atkarskaia MV; Burdennyĭ AM; Zavarykina TM; Kazubskaia TP; Nosikov VV; Braga ÉA; Zhizhina GP
    Mol Biol (Mosk); 2014; 48(1):62-8. PubMed ID: 25842826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in TP53 and MDM2 contribute to higher risk of colorectal cancer in Chinese population: a hospital-based, case-control study.
    Zhang Y; Liu L; Tang Y; Chen C; Wang Q; Xu J; Yang C; Miao X; Wei S; Chen J; Nie S
    Mol Biol Rep; 2012 Oct; 39(10):9661-8. PubMed ID: 22744426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival.
    Toffoli G; Biason P; Russo A; De Mattia E; Cecchin E; Hattinger CM; Pasello M; Alberghini M; Ferrari C; Scotlandi K; Picci P; Serra M
    Clin Cancer Res; 2009 May; 15(10):3550-6. PubMed ID: 19451596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian women.
    Krivokuca AM; Cavic MR; Malisic EJ; Rakobradovic JD; Kolarevic-Ivankovic D; Tomasevic ZI; Brankovic-Magic MV
    Int J Biol Markers; 2016 Jul; 31(3):e258-63. PubMed ID: 26954070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.
    Thurow HS; Hartwig FP; Alho CS; Silva DS; Roesler R; Abujamra AL; de Farias CB; Brunetto AL; Horta BL; Dellagostin OA; Collares T; Seixas FK
    Mol Biol Rep; 2013 Aug; 40(8):4929-34. PubMed ID: 23661019
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Cavic M; Spasic J; Krivokuca A; Boljevic I; Kuburovic M; Radosavljevic D; Jankovic R
    J Clin Pathol; 2019 Jan; 72(1):75-80. PubMed ID: 30467244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arg399Gln substitution in XRCC1 as a prognostic and predictive biomarker for prostate cancer: Evidence from 8662 subjects and a structural analysis.
    Noureddini M; Mobasseri N; Karimian M; Behjati M; Nikzad H
    J Gene Med; 2018 Oct; 20(10-11):e3053. PubMed ID: 30160806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
    Xia S; Wu S; Wang M
    Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA repair genes hOGG1, XRCC1 and ERCC2 polymorphisms and their molecular mapping in breast cancer patients from India.
    Rajagopal T; Seshachalam A; Rathnam KK; Jothi A; Viswanathan S; Talluri S; Dunna NR
    Mol Biol Rep; 2020 Jul; 47(7):5081-5090. PubMed ID: 32519309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic polymorphisms in DNA repair genes XRCC1 and 3 are associated with increased risk of breast cancer in Bangladeshi population.
    Howlader NR; Rahman MM; Hossain MA; Sultana R; Hossain SM; Mazid MA; Rahman MM
    Breast Cancer Res Treat; 2020 Aug; 182(3):739-750. PubMed ID: 32562117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.
    Cheng H; Ma B; Jiang R; Wang W; Guo H; Shen N; Li D; Zhao Q; Wang R; Yi P; Zhao Y; Liu Z; Huang T
    Mol Biol Rep; 2012 Sep; 39(9):9265-74. PubMed ID: 22729912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
    Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
    Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of polymorphism in MDM-2 and p53 genes with breast cancer risk in Indian women.
    Singh V; Rastogi N; Mathur N; Singh K; Singh MP
    Ann Epidemiol; 2008 Jan; 18(1):48-57. PubMed ID: 17719241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
    Abderrahmane R; Louhibi L; Moghtit FZ; Boubekeur A; Benseddik K; Boudjema A; Benrrahal F; Aberkane M; Fodil M; Saidi-Mehtar N
    Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.